• 1
    Mosmann, T. R. and Coffman, R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145173.
  • 2
    Annunziato, F. and Romagnani, S., Heterogeneity of human effector CD4+ T cells. Arthritis Res. Ther. 2009. 11: 257.
  • 3
    Swain, S. L., McKinstry, K. K. and Strutt, T. M., Expanding roles for CD4(+) T cells in immunity to viruses. Nat. Rev. Immunol. 2012. 12: 136148.
  • 4
    Coffman, R. L., Mechanisms of helper T-cell regulation of B-cell activity. Ann. NY Acad. Sci. 1993. 681: 2528.
  • 5
    Sanderson, C. J., Interleukin-5, eosinophils, and disease. Blood 1992. 79: 31013109.
  • 6
    Rankin, S. M., Conroy, D. M. and Williams, T. J., Eotaxin and eosinophil recruitment: implications for human disease. Mol. Med. Today 2000. 6: 2027.
  • 7
    Wynn, T. A., IL-13 effector functions. Annu. Rev. Immunol. 2003. 21: 425456.
  • 8
    Isaacs, A. and Lindenmann, J., Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 1957. 147: 258267.
  • 9
    Rubinstein, M., Rubinstein, S., Familletti, P. C., Gross, M. S., Miller, R. S., Waldman, A. A. and Pestka, S., Human leukocyte interferon purified to homogeneity. Science 1978. 202: 12891290.
  • 10
    Nagata, S., Mantei, N. and Weissmann, C., The structure of one of the eight or more distinct chromosomal genes for human interferon-alpha. Nature 1980. 287: 401408.
  • 11
    Pestka, S., Krause, C. D. and Walter, M. R., Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 2004. 202: 832.
  • 12
    Chen, J., Baig, E. and Fish, E. N., Diversity and relatedness among the type I interferons. J. Interferon Cytokine Res. 2004. 24: 687698.
  • 13
    Donnelly, R. P. and Kotenko, S. V., Interferon-lambda: a new addition to an old family. J. Interferon Cytokine Res. 2010. 30: 555564.
  • 14
    Kalie, E., Jaitin, D. A., Podoplelova, Y., Piehler, J. and Schreiber, G., The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities. J. Biol. Chem. 2008. 283: 3292532936.
  • 15
    Lavoie, T. B., Kalie, E., Crisafulli-Cabatu, S., Abramovich, R., DiGioia, G., Moolchan, K., Pestka, S. et al., Binding and activity of all human alpha interferon subtypes. Cytokine 2011. 56: 282289.
  • 16
    Hillyer, P., Mane, V. P., Schramm, L. M., Puig, M., Verthelyi, D., Chen, A., Zhao, Z. et al., Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent. Immunol. Cell Biol. 2012. 90: 774783.
  • 17
    Demeure, C. E., Wu, C. Y., Shu, U., Schneider, P. V., Heusser, C., Yssel, H. and Delespesse, G., In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J. Immunol. 1994. 152: 47754782.
  • 18
    Parronchi, P., Mohapatra, S., Sampognaro, S., Giannarini, L., Wahn, U., Chong, P., Maggi, E. et al., Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells. Eur. J. Immunol. 1996. 26: 697703.
  • 19
    Ramos, H. J., Davis, A. M., George, T. C. and Farrar, J. D., IFN-alpha is not sufficient to drive Th1 development due to lack of stable T-bet expression. J. Immunol. 2007. 179: 37923803.
  • 20
    Rogge, L., D'Ambrosio, D., Biffi, M., Penna, G., Minetti, L. J., Presky, D. H., Adorini, L. et al., The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 1998. 161: 65676574.
  • 21
    Huber, J. P., Ramos, H. J., Gill, M. A. and Farrar, J. D., Cutting edge: type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J. Immunol. 2010. 185: 813817.
  • 22
    Wakim, L. M., Gebhardt, T., Heath, W. R. and Carbone, F. R., Cutting edge: local recall responses by memory T cells newly recruited to peripheral nonlymphoid tissues. J. Immunol. 2008. 181: 58375841.
  • 23
    Chapman, T. J., Lambert, K. and Topham, D. J., Rapid reactivation of extralymphoid CD4 T cells during secondary infection. PLoS One 2011. 6: e20493.
  • 24
    Frentsch, M., Arbach, O., Kirchhoff, D., Moewes, B., Worm, M., Rothe, M., Scheffold, A. et al., Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 2005. 11: 11181124.
  • 25
    Meier, S., Stark, R., Frentsch, M. and Thiel, A., The influence of different stimulation conditions on the assessment of antigen-induced CD154 expression on CD4+ T cells. Cytometry A 2008. 73: 10351042.
  • 26
    Sylwester, A. W., Mitchell, B. L., Edgar, J. B., Taormina, C., Pelte, C., Ruchti, F., Sleath, P. R. et al., Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 2005. 202: 673685.
  • 27
    Lachmann, R., Bajwa, M., Vita, S., Smith, H., Cheek, E., Akbar, A. and Kern, F., Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses. J. Virol. 2012. 86: 10011009.
  • 28
    Casazza, J. P., Betts, M. R., Price, D. A., Precopio, M. L., Ruff, L. E., Brenchley, J. M., Hill, B. J. et al., Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J. Exp. Med. 2006. 203: 28652877.
  • 29
    Zhang, L., Peeples, M. E., Boucher, R. C., Collins, P. L. and Pickles, R. J., Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 2002. 76: 56545666.
  • 30
    Le Nouen, C., Hillyer, P., Munir, S., Winter, C. C., McCarty, T., Bukreyev, A., Collins, P. L. et al., Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells. PLoS One 2010. 5: e15017.
  • 31
    Le Nouen, C., Munir, S., Losq, S., Winter, C. C., McCarty, T., Stephany, D. A., Holmes, K. L. et al., Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. Virology 2009. 385: 169182.
  • 32
    Le Nouen, C., Hillyer, P., Winter, C. C., McCarty, T., Rabin, R. L., Collins, P. L. and Buchholz, U. J., Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus. PLoS Pathog. 2011. 7: e1002105.
  • 33
    Baig, E. and Fish, E. N., Distinct signature type I interferon responses are determined by the infecting virus and the target cell. Antivir. Ther. 2008. 13: 409422.
  • 34
    Hervas-Stubbs, S., Perez-Gracia, J. L., Rouzaut, A., Sanmamed, M. F., Le Bon, A. and Melero, I., Direct effects of type I interferons on cells of the immune system. Clin. Cancer Res. 2011. 17: 26192627.
  • 35
    Hilkens, C. M., Schlaak, J. F. and Kerr, I. M., Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J. Immunol. 2003. 171: 52555263.
  • 36
    Brinkmann, V., Geiger, T., Alkan, S. and Heusser, C. H., Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J. Exp. Med. 1993. 178: 16551663.
  • 37
    Golding, A., Rosen, A., Petri, M., Akhter, E. and Andrade, F., Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses. Immunology 2010. 131: 107117.
  • 38
    Rep, M. H., Hintzen, R. Q., Polman, C. H. and van Lier, R. A., Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. J. Neuroimmunol. 1996. 67: 111118.
  • 39
    Schandene, L., Del Prete, G. F., Cogan, E., Stordeur, P., Crusiaux, A., Kennes, B., Romagnani, S. et al., Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J. Clin. Invest. 1996. 97: 309315.
  • 40
    Shibuya, H. and Hirohata, S., Differential effects of IFN-alpha on the expression of various TH2 cytokines in human CD4+ T cells. J. Allergy Clin. Immunol. 2005. 116: 205212.
  • 41
    Essayan, D. M., Krishnaswamy, G., Oriente, A., Lichtenstein, L. M. and Huang, S. K., Differential regulation of antigen-induced IL-4 and IL-13 generation from T lymphocytes by IFN-alpha. J. Allergy Clin. Immunol. 1999. 103: 451457.
  • 42
    Aman, M. J., Tretter, T., Eisenbeis, I., Bug, G., Decker, T., Aulitzky, W. E., Tilg, H. et al., Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood 1996. 87: 47314736.
  • 43
    Feng, X., Yau, D., Holbrook, C. and Reder, A. T., Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T cells: implications for Th1-mediated diseases. J. Interferon Cytokine Res. 2002. 22: 311319.
  • 44
    Jabs, W. J., Hennig, C., Zawatzky, R. and Kirchner, H., Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta. J. Interferon Cytokine Res. 1999. 19: 463469.
  • 45
    Kaiser, L., Fritz, R. S., Straus, S. E., Gubareva, L. and Hayden, F. G., Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J. Med. Virol. 2001. 64: 262268.
  • 46
    Tyler, D. R., Persky, M. E., Matthews, L. A., Chan, S. and Farrar, J. D., Pre-assembly of STAT4 with the human IFN-alpha/beta receptor-2 subunit is mediated by the STAT4 N-domain. Mol. Immunol. 2007. 44: 18641872.
  • 47
    Zhu, J., Cote-Sierra, J., Guo, L. and Paul, W. E., Stat5 activation plays a critical role in Th2 differentiation. Immunity 2003. 19: 739748.
  • 48
    Rani, A., Afzali, B., Kelly, A., Tewolde-Berhan, L., Hackett, M., Kanhere, A. S., Pedroza-Pacheco, I. et al., IL-2 regulates expression of C-MAF in human CD4 T cells. J. Immunol. 2011. 187: 37213729.
  • 49
    Ho, I. C., Hodge, M. R., Rooney, J. W. and Glimcher, L. H., The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 1996. 85: 973983.
  • 50
    Gallagher, K. M., Lauder, S., Rees, I. W., Gallimore, A. M. and Godkin, A. J., Type I interferon (IFN alpha) acts directly on human memory CD4+ T cells altering their response to antigen. J. Immunol. 2009. 183: 29152920.
  • 51
    Makedonas, G. and Betts, M. R., Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin. Immunopathol. 2006. 28: 209219.
  • 52
    Seder, R. A., Darrah, P. A. and Roederer, M., T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 2008. 8: 247258.
  • 53
    Stewart, T. A., Hultgren, B., Huang, X., Pitts-Meek, S., Hully, J. and MacLachlan, N. J., Induction of type I diabetes by interferon-alpha in transgenic mice. Science 1993. 260: 19421946.
  • 54
    Subrata, L. S., Bizzintino, J., Mamessier, E., Bosco, A., McKenna, K. L., Wikstrom, M. E., Goldblatt, J. et al., Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J. Immunol. 2009. 183: 27932800.
  • 55
    Gill, M. A., Bajwa, G., George, T. A., Dong, C. C., Dougherty, II, Jiang, N., Gan, V. N. et al., Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J. Immunol. 2010. 184: 59996006.
  • 56
    Grayson, M. H., Cheung, D., Rohlfing, M. M., Kitchens, R., Spiegel, D. E., Tucker, J., Battaile, J. T. et al., Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia. J. Exp. Med. 2007. 204: 27592769.
  • 57
    Stone, K. D., Prussin, C. and Metcalfe, D. D., IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 2010. 125: S7380.
  • 58
    Luttmann, W., Matthiesen, T., Matthys, H. and Virchow, J. C., Jr., Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-alpha on eosinophil activation in vitro. Am. J. Respir. Cell Mol. Biol. 1999. 20: 474480.
  • 59
    Anderson, R., Huang, Y. and Langley, J. M., Prospects for defined epitope vaccines for respiratory syncytial virus. Future Microbiol. 2010. 5: 585602.
  • 60
    Rubinstein, S., Familletti, P. C. and Pestka, S., Convenient assay for interferons. J. Virol. 1981. 37: 755758.
  • 61
    Munir, S., Hillyer, P., Le Nouen, C., Buchholz, U. J., Rabin, R. L., Collins, P. L. and Bukreyev, A., Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog. 2011. 7: e1001336.
  • 62
    Roederer, M., Nozzi, J. L. and Nason, M. C., SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011. 79: 167174.